|
PDXDC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.588700E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.96410000000392E-05 |
| Normal-vs-Stage2 |
3.802400E-02 |
| Normal-vs-Stage3 |
8.597600E-01 |
| Normal-vs-Stage4 |
1.780590E-01 |
| Stage1-vs-Stage2 |
9.208400E-01 |
| Stage1-vs-Stage3 |
4.213600E-02 |
| Stage1-vs-Stage4 |
8.191000E-01 |
| Stage2-vs-Stage3 |
1.244800E-01 |
| Stage2-vs-Stage4 |
8.936000E-01 |
| Stage3-vs-Stage4 |
2.821400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.579600E-03 |
| Normal-vs-AfricanAmerican |
1.429060E-04 |
| Normal-vs-Asian |
2.158000E-03 |
| Caucasian-vs-AfricanAmerican |
8.995700E-02 |
| Caucasian-vs-Asian |
2.682200E-01 |
| AfricanAmerican-vs-Asian |
4.506400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.159200E-04 |
| Normal-vs-Female |
4.266300E-02 |
| Male-vs-Female |
4.574600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.843200E-04 |
| Normal-vs-Extreme_Weight |
2.04969999999527E-05 |
| Normal-vs-Obese |
2.213400E-01 |
| Normal-vs-Extreme_Obese |
4.506300E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.121000E-01 |
| Normal_Weight-vs-Obese |
2.360400E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.824200E-01 |
| Extreme_Weight-vs-Obese |
1.268480E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.464800E-01 |
| Obese-vs-Extreme_Obese |
1.930960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.793000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.933500E-02 |
| Normal-vs-Age(61-80Yrs) |
2.562300E-04 |
| Normal-vs-Age(81-100Yrs) |
3.780800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.361000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.932000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.363020E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.336040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.548420E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.379200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.012400E-04 |
| Normal-VS-Type2 PRCC |
2.736100E-02 |
| Normal-VS-KIRP CIMP |
6.696600E-01 |
| Normal-VS-Unclassified PRCC |
6.357600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.680400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.524400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.146300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.705770E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.766400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.417400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.152440E-01 |
| Normal-vs-N1 |
6.769000E-01 |
| Normal-vs-N2 |
5.596000E-01 |
| N0-vs-N1 |
4.778600E-01 |
| N0-vs-N2 |
8.268400E-01 |
| N1-vs-N2 |
5.729200E-01 |
|
|
